Developer docs
API playgroundTry for free, no card

Search company profiles

Afriplex

Full company profile

uuid000beu6

Namestring
Afriplex
Legal namestring
Afriplex (Pty) Ltd
Websiteurl
afriplex.co.za
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Afriplex (Pty) Ltd is a South African botanical extracts and contract manufacturer founded in 2001, headquartered in Paarl, Western Cape, with a regional sales office in Johannesburg. The company develops and manufactures proprietary Active Pharmaceutical Ingredients (APIs) including Afriplex GRT™ (Rooibos-derived for metabolic syndrome), Afriplex Corac-Q™ (respiratory health), Folicin A/T (hair loss), and Pelargonium S70 (respiratory infections), alongside botanical extracts (Rooibos, Honeybush, Buchu, Moringa, Kigelia), essential oils, functional ingredients, and the LIPOZOME® liposome delivery platform. Afriplex operates cGMP-compliant manufacturing facilities including spray drying, solid dosage forms (via the 2017 acquisition of Edelweiss Pharmaceutical), a 1,000 sqm tea packing plant, and a dedicated Cannabis Laboratory, and is described as the only licensed GMP cannabis manufacturer in South Africa. The business model is B2B contract manufacturing and ingredient supply to pharmaceutical, cosmetic, nutraceutical, and food & beverage companies, supported by GL

Short descriptiontext

Afriplex is a South African B2B contract manufacturer and developer of proprietary botanical APIs, extracts, and complementary medicines, serving pharmaceutical, cosmetic, nutraceutical, food & beverage, and licensed cannabis clients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPaarl, South Africa
HQ citystring
Paarl
HQ countrystring
South Africa
HQ regionstring
Africa
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
botanical extracts manufacturing, pharmaceutical contract manufacturing, complementary medicines supply, cannabis extraction services, active pharmaceutical ingredients
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Pharmaceutical Contract Manufacturing
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Botanical Extracts Manufacturing
TypeOne Time License
Description

Manufacture and supply of botanical extracts (liquid and powder) to pharmaceutical, cosmetic, nutraceutical, and food & beverage industries. Products include Rooibos, Honeybush, Buchu, Rosehip, Moringa, and other African indigenous plant extracts.

afriplex.co.za
2Active Pharmaceutical Ingredients (APIs)
TypeOne Time License
Description

Development and manufacturing of proprietary APIs including Afriplex GRT™ (Rooibos), Pelargonium S70, Folicin A/T, Rosehip C, and cannabis-derived APIs. Supported by APIMF development.

afriplex.co.za
3Contract Manufacturing Services
TypeProfessional Services
Description

cGMP-compliant manufacturing of final products including tablets, capsules, syrups, drops, creams, teas and other dosage forms for CAMs and health supplements.

afriplex.co.za
4Laboratory Services
TypeProfessional Services
Description

Routine laboratory analysis, CTD compilation, stability testing, and quality control services. In-house GLP-compliant laboratories for general chemistry, instrumentation, microbial analysis.

afriplex.co.za
5Functional Food & Beverage Solutions
TypeOne Time License
Description

Product development and conceptualization of novel functional food and beverage products using botanical extracts, including vegan milk alternatives and functional teas.

afriplex.co.za
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Pricing details1 tier
1B2B ingredient and API sales
ModelOtherBilling cadenceMulti-year contract
Notes

Contact-based pricing for botanical extracts, APIs, and manufacturing services. No public pricing available.

afriplex.co.za
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1Afriplex GRT
Description

Active Pharmaceutical Ingredient derived from rooibos (Aspalathus linearis) targeting metabolic syndrome, diabetes, and cholesterol management

afriplex.co.za
+7 more records
Core offering1 text field

Afriplex manufactures and supplies standardized botanical extracts, proprietary Active Pharmaceutical Ingredients (APIs), and contract-manufactured finished dosage forms (tablets, capsules, syrups, drops, creams, teas) for pharmaceutical, nutraceutical, cosmetic, and food & beverage companies. It is the only SAHPRA-licensed GMP cannabis manufacturer in South Africa and offers cGMP-compliant contract manufacturing, GLP laboratory testing, CTD compilation, and APIMF development services alongside its proprietary LIPOZOME® liposome drug delivery platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • CBD isolate extraction technology developed for local cannabis - first in South Africa
+2 more records
Product overview1 text field

Afriplex is a South African botanical extracts supplier and contract manufacturer established in 2001, specializing in Complementary & Alternative Medicines (CAMs), pharmaceutical ingredients, and functional food & beverage solutions. The portfolio centers on proprietary Active Pharmaceutical Ingredients (APIs) including Afriplex GRT™ (rooibos-based metabolic disorder treatment), Afriplex PS70 (Pelargonium-based respiratory treatment), Folicin A/T (hair loss treatment), and Afriplex Corac-Q™ (respiratory health). The company offers a comprehensive range of botanical extracts, essential oils, and plant materials derived from African indigenous plants (Rooibos, Honeybush, Buchu, Moringa, Baobab), supplemented by cannabis manufacturing capabilities (vapes, edibles, distillates, CBD isolates). Manufacturing services include cGMP-compliant tablet/capsule production, spray drying, GLP laboratory testing, CTD compilation, and the proprietary LIPOZOME® liposome drug delivery technology. The company operates cannabis testing and extraction facilities under SAHPRA licensing and acquired Edelweiss Pharmaceutical in 2017 to expand solid dosage manufacturing capacity.

Product and service18 records
1Afriplex GRT™
CategoryAPI product
Description

Proprietary rooibos-derived API standardized on aspalathin flavonoid, marketed to pharmaceutical manufacturers for metabolic syndrome, diabetes and cholesterol management applications.

2Afriplex PS70 (Pelargonium S70)
CategoryAPI product
Description

Pelargonium sidoides-derived API for respiratory infections, sold to pharmaceutical and nutraceutical manufacturers in liquid form for use in multiple dosage formats.

3Folicin A/T
CategoryAPI product
Description

API phyto extract from Elephantorrhiza elephantina acting as a 5α-reductase inhibitor, supplied to pharmaceutical customers for male pattern baldness, BPH, acne vulgaris and androgenic alopecia formulations.

4Afriplex Corac-Q™
CategoryAPI product
Description

Plant-based respiratory health API combining Aspalathin (from Rooibos), Quercetin, Zinc and Vitamin D, marketed to nutraceutical and pharmaceutical manufacturers for antiviral and immune-stimulating formulations.

5Afriplex® Bromelain
CategoryEnzyme ingredient
Description

Proteolytic enzyme extract from pineapple stem standardized in a range of GDU strengths, supplied to pharmaceutical, topical, veterinary and supplement manufacturers for anti-inflammatory, mucolytic and digestive applications.

6Afriplex® Moringa B
CategoryNutraceutical ingredient
Description

Water-soluble Moringa oleifera powder extract standardized on B vitamins (B1, B2, B3, B5, B6, B7, B9, B12) at 100% NRV, supplied as a functional food and nutraceutical ingredient.

7Afriplex® C-Ferin
CategoryNutraceutical ingredient
Description

Honeybush (Cyclopia spp.) extract standardized on Mangiferin at 5% and 30% concentrations, supplied as a nutraceutical and functional beverage ingredient.

8Pelagon Range
CategoryBotanical extract
Description

Pelargonium sidoides extract range standardized on unique flavonoids for food supplement applications with antibacterial, antiviral and immunomodulatory properties, positioned for the European market.

9Botanical Extracts Portfolio
CategoryBotanical ingredient
Description

Liquid and spray-dried powder extracts of African indigenous plants (Rooibos, Honeybush, Buchu, Pelargonium, Moringa, Aloe Vera, Echinacea, Sutherlandia, Kigelia, Rosehip, Baobab), supplied as bulk raw materials to pharmaceutical, nutraceutical, cosmetic and food & beverage manufacturers.

10Essential Oils
CategoryBotanical ingredient
Description

Natural and essential oils (Rosehip, Buchu, Baobab, Marula, Moringa) produced by cold pressing or steam distillation, supplied to cosmetic and food supplement formulators.

11Cannabis Finished Products
CategoryCannabis product
Description

SAHPRA-licensed GMP-manufactured cannabis products including vapes, edibles (gummies), distillates and CBD isolates, supplied to licensed cultivators and brand owners for local and export markets.

12Functional Teas
CategoryFinished tea product
Description

CBD-plated Rooibos tea and immune-boosting functional teas with liposomal Pelagon™ extract, supplied in bulk, sachet or finished GMP-compliant packaging for brand owners and retailers.

13Functional Vegan Milk Ingredients
CategoryFunctional beverage ingredient
Description

Plant-based milk concentrates (macadamia, almond, cashew, pecan, oat) with optional botanical fortification using Rooibos, Honeybush and Moringa extracts, supplied as functional beverage ingredients.

14Afriplex Propolis Extract
CategoryBotanical ingredient
Description

Standardized propolis extract with antiseptic, anti-inflammatory, antifungal and immunomodulatory properties, supplied as an active ingredient for cosmetic and food supplement formulations.

15LIPOZOME® Liposome Technology
CategoryDrug delivery technology
Description

Commercialized liposome drug-delivery technology sold to formulators, offering improved bioavailability, protection against degradation, unpleasant flavour masking and targeted delivery of active ingredients.

16cGMP Contract Manufacturing Services
CategoryContract manufacturing
Description

Contract manufacturing of finished CAM and supplement dosage forms (tablets, capsules, syrups, drops, creams, teas) at cGMP standards, supplied to brand owners seeking turnkey production.

17GLP Laboratory Analysis Services
CategoryLaboratory services
Description

GLP-compliant laboratory services covering general chemistry, instrumental analysis (HPLC, TLC, GC), stability testing and microbial analysis, delivered to pharmaceutical, nutraceutical and cannabis clients.

18CTD Compilation Services
CategoryRegulatory services
Description

Common Technical Document (CTD) compilation support for SAHPRA Complementary Medicines registration, delivered to clients seeking regulatory dossier assistance.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
1Cannabis Research Institute (CRI)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-03-27
Description

Afriplex is a member of the CRI and their dedicated Cannabis Laboratory was nominated as the laboratory of choice by the Institute. The CRI leads novel research and development projects in collaboration with international research organizations. Afriplex works with CRI on cannabis processing facilities, track & trace systems, and regulatory compliance.

afriplex.co.za
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Afriplex provides analytical services to CloneLabs, a biotechnology company providing licensed cannabis cultivators with high-quality clones propagated using micropropagation techniques. CloneLabs leverages Afriplex's quality control and analysis capabilities.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2020-08-27
Description

Media partnership for The Business Day Cannabis Economy LIVE webinar series. Provides platform for discussing cannabis industry topics and economic opportunities.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2020-01-01
Description

Trade, tourism and investment promotion agency for Cape Town and Western Cape. Supports Afriplex's export initiatives and positions Western Cape as a medicinal cannabis hub.

5House of Hemp
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Strategic partner that received SAHPRA's first Cannabis Cultivation License. Afriplex and House of Hemp worked together for seven years to meet local standards and international legislative requirements for cannabis production.

afriplex.co.za
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

International research collaboration on novel cannabis research projects. Collaborative research aims to develop new technologies and products for the cannabis industry.

7South African Medical Research Council (SAMRC)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-03-08
Description

Partnership for development of Afriplex GRT™, the first SA-developed Rooibos API. SAMRC conducted research indicating rooibos flavonoid compounds play a role in cholesterol regulation and blood glucose level management.

afriplex.co.za
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-03-08
Description

Partnered with SAMRC and Afriplex in developing Afriplex GRT™ API. ARC contributes agricultural expertise for rooibos cultivation and raw material quality.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2018-01-01
Description

Afriplex is the local agent for this innovative French company offering novel actives for nutraceutical applications including Memophenol (brain memory), SkinAx2 (beauty from within), and Safr'Inside (mood balance).

10Council of Scientific and Industrial Research (CSIR)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2017-02-05
Description

Collaboration on APIMF (Active Pharmaceutical Ingredient Master Files) development program supporting APIs like Folicin A/T and Afriplex GRT. CSIR assists with safety and efficacy data generation.

afriplex.co.za
11Edelweiss Pharmaceutical
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2017-02-01
Description

Acquired by Afriplex in 2017. Acquisition complemented Afriplex's existing business and offered Edelweiss clients access to botanical APIs, R&D services, quality assurance, and CTD compilation support.

afriplex.co.za
Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Horphag Research
TypeEmerging player
Description

Swiss/US supplier of branded, patented polyphenol ingredients (e.g., Pycnogenol). Comparable in the strategy of building IP-protected, science-backed branded ingredients from a single botanical source — similar to Afriplex GRT™ and Folicin A/T.

TypeBroad incumbent
Description

Swiss global leader in flavors, fragrances, and natural ingredients (including the Naturex botanical portfolio). Overlaps with Afriplex on botanical extracts and functional food/beverage ingredients, but operates at much larger scale with broader portfolio.

TypeBroad incumbent
Description

German major in flavors, nutrition, and cosmetic ingredients with a meaningful botanical extracts business. Competes for the same functional food, beverage, and personal care brand-owner customers as Afriplex, though as part of a much wider portfolio.

TypeDirect peer
Description

Indian manufacturer of standardized herbal extracts, APIs, and nutraceutical ingredients with global B2B distribution. Comparable on standardized botanical APIs, dosage forms, and contract manufacturing.

TypeDirect peer
Description

US/India-based manufacturer of branded, science-backed botanical extracts and specialty ingredients. Comparable to Afriplex's proprietary API/branded ingredient strategy (e.g., GRT™, Corac-Q™).

TypeDirect peer
Description

Italian manufacturer of high-quality standardized botanical extracts and APIs for the pharmaceutical and nutraceutical industries. Most directly comparable to Afriplex in business model (plant-derived APIs, cGMP, global B2B sales).

TypeBroad incumbent
Description

US-based ingredient manufacturer for human/animal nutrition, health, and beauty. Overlaps with Afriplex on functional botanical ingredients and F&B solutions, though at significantly larger scale and broader category exposure.

TypeDirect peer
Description

French supplier of plant-based ingredients for nutraceutical, food, and beverage markets. Comparable B2B ingredient model and focus on functional/scientifically validated botanical actives.

9Martin Bauer Group
TypeDirect peer
Description

German-headquartered global leader in botanical extracts, teas, and plant-based ingredients for beverages, nutrition, and pharma. Comparable to Afriplex in vertically integrated plant-to-ingredient model and tea-packing capabilities.

TypeDirect peer
Description

Spanish producer of standardized botanical extracts for pharma, nutraceutical, and food applications. Closely aligned with Afriplex on standardized extract portfolio, cGMP manufacturing, and API development focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Afriplex

Pharmaceutical Contract Manufacturingafriplex.co.za

Afriplex is a South African B2B contract manufacturer and developer of proprietary botanical APIs, extracts, and complementary medicines, serving pharmaceutical, cosmetic, nutraceutical, food & beverage, and licensed cannabis clients.

What Afriplex does

Afriplex (Pty) Ltd is a South African botanical extracts and contract manufacturer founded in 2001, headquartered in Paarl, Western Cape, with a regional sales office in Johannesburg. The company develops and manufactures proprietary Active Pharmaceutical Ingredients (APIs) including Afriplex GRT™ (Rooibos-derived for metabolic syndrome), Afriplex Corac-Q™ (respiratory health), Folicin A/T (hair loss), and Pelargonium S70 (respiratory infections), alongside botanical extracts (Rooibos, Honeybush, Buchu, Moringa, Kigelia), essential oils, functional ingredients, and the LIPOZOME® liposome delivery platform. Afriplex operates cGMP-compliant manufacturing facilities including spray drying, solid dosage forms (via the 2017 acquisition of Edelweiss Pharmaceutical), a 1,000 sqm tea packing plant, and a dedicated Cannabis Laboratory, and is described as the only licensed GMP cannabis manufacturer in South Africa. The business model is B2B contract manufacturing and ingredient supply to pharmaceutical, cosmetic, nutraceutical, and food & beverage companies, supported by GL

Afriplex firmographics

Firmographics
Name
Afriplex
Legal name
Afriplex (Pty) Ltd
Website
https://afriplex.co.za
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
51–100 employees
Short description
Afriplex is a South African B2B contract manufacturer and developer of proprietary botanical APIs, extracts, and complementary medicines, serving pharmaceutical, cosmetic, nutraceutical, food & beverage, and licensed cannabis clients.
Ownership category
akta.pro rank

Where Afriplex is headquartered

Location

Headquarters

HQ city
Paarl
HQ country
South Africa
HQ region
Africa

Offices2 records

Markets served

Afriplex business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Botanical Extracts Manufacturing: Manufacture and supply of botanical extracts (liquid and powder) to pharmaceutical, cosmetic, nutraceutical, and food & beverage industries. Products include Rooibos, Honeybush, Buchu, Rosehip, Moringa, and other African indigenous plant extracts.
  2. Active Pharmaceutical Ingredients (APIs): Development and manufacturing of proprietary APIs including Afriplex GRT™ (Rooibos), Pelargonium S70, Folicin A/T, Rosehip C, and cannabis-derived APIs. Supported by APIMF development.
  3. Contract Manufacturing Services: cGMP-compliant manufacturing of final products including tablets, capsules, syrups, drops, creams, teas and other dosage forms for CAMs and health supplements.
  4. Laboratory Services: Routine laboratory analysis, CTD compilation, stability testing, and quality control services. In-house GLP-compliant laboratories for general chemistry, instrumentation, microbial analysis.
  5. Functional Food & Beverage Solutions: Product development and conceptualization of novel functional food and beverage products using botanical extracts, including vegan milk alternatives and functional teas.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B ingredient and API sales

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Afriplex product offering

Product offering

Core offering

Afriplex manufactures and supplies standardized botanical extracts, proprietary Active Pharmaceutical Ingredients (APIs), and contract-manufactured finished dosage forms (tablets, capsules, syrups, drops, creams, teas) for pharmaceutical, nutraceutical, cosmetic, and food & beverage companies. It is the only SAHPRA-licensed GMP cannabis manufacturer in South Africa and offers cGMP-compliant contract manufacturing, GLP laboratory testing, CTD compilation, and APIMF development services alongside its proprietary LIPOZOME® liposome drug delivery platform.

Product overview

Afriplex is a South African botanical extracts supplier and contract manufacturer established in 2001, specializing in Complementary & Alternative Medicines (CAMs), pharmaceutical ingredients, and functional food & beverage solutions. The portfolio centers on proprietary Active Pharmaceutical Ingredients (APIs) including Afriplex GRT™ (rooibos-based metabolic disorder treatment), Afriplex PS70 (Pelargonium-based respiratory treatment), Folicin A/T (hair loss treatment), and Afriplex Corac-Q™ (respiratory health). The company offers a comprehensive range of botanical extracts, essential oils, and plant materials derived from African indigenous plants (Rooibos, Honeybush, Buchu, Moringa, Baobab), supplemented by cannabis manufacturing capabilities (vapes, edibles, distillates, CBD isolates). Manufacturing services include cGMP-compliant tablet/capsule production, spray drying, GLP laboratory testing, CTD compilation, and the proprietary LIPOZOME® liposome drug delivery technology. The company operates cannabis testing and extraction facilities under SAHPRA licensing and acquired Edelweiss Pharmaceutical in 2017 to expand solid dosage manufacturing capacity.

Differentiator

Problem solved

Functional benefit

Brands

  • Afriplex GRT: Active Pharmaceutical Ingredient derived from rooibos (Aspalathus linearis) targeting metabolic syndrome, diabetes, and cholesterol management
  • Afriplex PS70
  • Pelagon
  • Afriplex Corac-Q
  • Afriplex Bromelain
  • LIPOZOME
  • Afriplex C-Ferin
  • Afriplex Moringa B

Products and services

  • Afriplex GRT™ Proprietary rooibos-derived API standardized on aspalathin flavonoid, marketed to pharmaceutical manufacturers for metabolic syndrome, diabetes and cholesterol management applications.
  • Afriplex PS70 (Pelargonium S70) Pelargonium sidoides-derived API for respiratory infections, sold to pharmaceutical and nutraceutical manufacturers in liquid form for use in multiple dosage formats.
  • Folicin A/T API phyto extract from Elephantorrhiza elephantina acting as a 5α-reductase inhibitor, supplied to pharmaceutical customers for male pattern baldness, BPH, acne vulgaris and androgenic alopecia formulations.
  • Afriplex Corac-Q™ Plant-based respiratory health API combining Aspalathin (from Rooibos), Quercetin, Zinc and Vitamin D, marketed to nutraceutical and pharmaceutical manufacturers for antiviral and immune-stimulating formulations.
  • Afriplex® Bromelain Proteolytic enzyme extract from pineapple stem standardized in a range of GDU strengths, supplied to pharmaceutical, topical, veterinary and supplement manufacturers for anti-inflammatory, mucolytic and digestive applications.
  • Afriplex® Moringa B Water-soluble Moringa oleifera powder extract standardized on B vitamins (B1, B2, B3, B5, B6, B7, B9, B12) at 100% NRV, supplied as a functional food and nutraceutical ingredient.
  • Afriplex® C-Ferin Honeybush (Cyclopia spp.) extract standardized on Mangiferin at 5% and 30% concentrations, supplied as a nutraceutical and functional beverage ingredient.
  • Pelagon Range Pelargonium sidoides extract range standardized on unique flavonoids for food supplement applications with antibacterial, antiviral and immunomodulatory properties, positioned for the European market.
  • Botanical Extracts Portfolio Liquid and spray-dried powder extracts of African indigenous plants (Rooibos, Honeybush, Buchu, Pelargonium, Moringa, Aloe Vera, Echinacea, Sutherlandia, Kigelia, Rosehip, Baobab), supplied as bulk raw materials to pharmaceutical, nutraceutical, cosmetic and food & beverage manufacturers.
  • Essential Oils Natural and essential oils (Rosehip, Buchu, Baobab, Marula, Moringa) produced by cold pressing or steam distillation, supplied to cosmetic and food supplement formulators.
  • Cannabis Finished Products SAHPRA-licensed GMP-manufactured cannabis products including vapes, edibles (gummies), distillates and CBD isolates, supplied to licensed cultivators and brand owners for local and export markets.
  • Functional Teas CBD-plated Rooibos tea and immune-boosting functional teas with liposomal Pelagon™ extract, supplied in bulk, sachet or finished GMP-compliant packaging for brand owners and retailers.
  • Functional Vegan Milk Ingredients Plant-based milk concentrates (macadamia, almond, cashew, pecan, oat) with optional botanical fortification using Rooibos, Honeybush and Moringa extracts, supplied as functional beverage ingredients.
  • Afriplex Propolis Extract Standardized propolis extract with antiseptic, anti-inflammatory, antifungal and immunomodulatory properties, supplied as an active ingredient for cosmetic and food supplement formulations.
  • LIPOZOME® Liposome Technology Commercialized liposome drug-delivery technology sold to formulators, offering improved bioavailability, protection against degradation, unpleasant flavour masking and targeted delivery of active ingredients.
  • cGMP Contract Manufacturing Services Contract manufacturing of finished CAM and supplement dosage forms (tablets, capsules, syrups, drops, creams, teas) at cGMP standards, supplied to brand owners seeking turnkey production.
  • GLP Laboratory Analysis Services GLP-compliant laboratory services covering general chemistry, instrumental analysis (HPLC, TLC, GC), stability testing and microbial analysis, delivered to pharmaceutical, nutraceutical and cannabis clients.
  • CTD Compilation Services Common Technical Document (CTD) compilation support for SAHPRA Complementary Medicines registration, delivered to clients seeking regulatory dossier assistance.

Quantifiable outcome

  • CBD isolate extraction technology developed for local cannabis - first in South Africa
  • +2 more outcomes

Companies that use Afriplex

Customer profile

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Afriplex technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Afriplex partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • Cannabis Research Institute (CRI)coreStrategic or Co-development Partner · 27 March 2023Afriplex is a member of the CRI and their dedicated Cannabis Laboratory was nominated as the laboratory of choice by the Institute. The CRI leads novel research and development projects in collaboration with international research organizations. Afriplex works with CRI on cannabis processing facilities, track & trace systems, and regulatory compliance.
  • CloneLabs (Pty) LtdcoreStrategic or Co-development Partner · 1 January 2021Afriplex provides analytical services to CloneLabs, a biotechnology company providing licensed cannabis cultivators with high-quality clones propagated using micropropagation techniques. CloneLabs leverages Afriplex's quality control and analysis capabilities.
  • Business DayminorGTM or Marketing Partner · 27 August 2020Media partnership for The Business Day Cannabis Economy LIVE webinar series. Provides platform for discussing cannabis industry topics and economic opportunities.
  • WesgrominorGTM or Marketing Partner · 1 January 2020Trade, tourism and investment promotion agency for Cape Town and Western Cape. Supports Afriplex's export initiatives and positions Western Cape as a medicinal cannabis hub.
  • House of HempcoreStrategic or Co-development Partner · 1 January 2019Strategic partner that received SAHPRA's first Cannabis Cultivation License. Afriplex and House of Hemp worked together for seven years to meet local standards and international legislative requirements for cannabis production.
  • Technical University of Dortmund (Prof. Oliver Kayser)minorStrategic or Co-development Partner · 1 January 2019International research collaboration on novel cannabis research projects. Collaborative research aims to develop new technologies and products for the cannabis industry.
  • South African Medical Research Council (SAMRC)coreStrategic or Co-development Partner · 8 March 2018Partnership for development of Afriplex GRT™, the first SA-developed Rooibos API. SAMRC conducted research indicating rooibos flavonoid compounds play a role in cholesterol regulation and blood glucose level management.
  • Agricultural Research Council (ARC)coreStrategic or Co-development Partner · 8 March 2018Partnered with SAMRC and Afriplex in developing Afriplex GRT™ API. ARC contributes agricultural expertise for rooibos cultivation and raw material quality.
  • Activ'InsideminorChannel Partner/ Reseller/ Distributor · 1 January 2018Afriplex is the local agent for this innovative French company offering novel actives for nutraceutical applications including Memophenol (brain memory), SkinAx2 (beauty from within), and Safr'Inside (mood balance).
  • Council of Scientific and Industrial Research (CSIR)coreStrategic or Co-development Partner · 5 February 2017Collaboration on APIMF (Active Pharmaceutical Ingredient Master Files) development program supporting APIs like Folicin A/T and Afriplex GRT. CSIR assists with safety and efficacy data generation.
  • Edelweiss PharmaceuticalminorStrategic or Co-development Partner · 1 February 2017Acquired by Afriplex in 2017. Acquisition complemented Afriplex's existing business and offered Edelweiss clients access to botanical APIs, R&D services, quality assurance, and CTD compilation support.

Scale indicators5 records

Recent moves12 records

Expansion highlights5 records

Afriplex competitors and assessment

Company assessment

Emerging players

  • Horphag Research: Swiss/US supplier of branded, patented polyphenol ingredients (e.g., Pycnogenol). Comparable in the strategy of building IP-protected, science-backed branded ingredients from a single botanical source — similar to Afriplex GRT™ and Folicin A/T.

Broad incumbents

  • Givaudan: Swiss global leader in flavors, fragrances, and natural ingredients (including the Naturex botanical portfolio). Overlaps with Afriplex on botanical extracts and functional food/beverage ingredients, but operates at much larger scale with broader portfolio.
  • Symrise: German major in flavors, nutrition, and cosmetic ingredients with a meaningful botanical extracts business. Competes for the same functional food, beverage, and personal care brand-owner customers as Afriplex, though as part of a much wider portfolio.
  • Kemin Industries: US-based ingredient manufacturer for human/animal nutrition, health, and beauty. Overlaps with Afriplex on functional botanical ingredients and F&B solutions, though at significantly larger scale and broader category exposure.

Direct peers

  • Botanic Healthcare: Indian manufacturer of standardized herbal extracts, APIs, and nutraceutical ingredients with global B2B distribution. Comparable on standardized botanical APIs, dosage forms, and contract manufacturing.
  • Sabinsa: US/India-based manufacturer of branded, science-backed botanical extracts and specialty ingredients. Comparable to Afriplex's proprietary API/branded ingredient strategy (e.g., GRT™, Corac-Q™).
  • Indena: Italian manufacturer of high-quality standardized botanical extracts and APIs for the pharmaceutical and nutraceutical industries. Most directly comparable to Afriplex in business model (plant-derived APIs, cGMP, global B2B sales).
  • Nexira: French supplier of plant-based ingredients for nutraceutical, food, and beverage markets. Comparable B2B ingredient model and focus on functional/scientifically validated botanical actives.
  • Martin Bauer Group: German-headquartered global leader in botanical extracts, teas, and plant-based ingredients for beverages, nutrition, and pharma. Comparable to Afriplex in vertically integrated plant-to-ingredient model and tea-packing capabilities.
  • Euromed: Spanish producer of standardized botanical extracts for pharma, nutraceutical, and food applications. Closely aligned with Afriplex on standardized extract portfolio, cGMP manufacturing, and API development focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Afriplex social profiles

Digital presence

Afriplex compliance and trust

Trust signal

Compliance4 records

Afriplex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Afriplex leadership team

Management profile

Number of profiles

Profiles7 records

Afriplex subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Afriplex funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Afriplex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Afriplex

What does Afriplex do?

Afriplex manufactures and supplies standardized botanical extracts, proprietary Active Pharmaceutical Ingredients (APIs), and contract-manufactured finished dosage forms (tablets, capsules, syrups, drops, creams, teas) for pharmaceutical, nutraceutical, cosmetic, and food & beverage companies. It is the only SAHPRA-licensed GMP cannabis manufacturer in South Africa and offers cGMP-compliant contract manufacturing, GLP laboratory testing, CTD compilation, and APIMF development services alongside its proprietary LIPOZOME® liposome drug delivery platform.

Is Afriplex a public or private company?

Afriplex is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Afriplex founded?

Afriplex was founded in 2001. It employs 51 to 100 people.

Where is Afriplex based?

Afriplex is headquartered in Paarl, South Africa, in the Africa region.

How does Afriplex make money?

Five revenue lines are on record. Botanical Extracts Manufacturing is the primary driver. The others are active Pharmaceutical Ingredients (APIs), contract Manufacturing Services, laboratory Services and functional Food & Beverage Solutions.

Who are Afriplex's main competitors?

Horphag Research is listed as an emerging player. Broad incumbents are Givaudan, Symrise and Kemin Industries. Direct peers are Botanic Healthcare, Sabinsa, Indena, Nexira, Martin Bauer Group and Euromed.

Does Afriplex have an API?

No public API is recorded for Afriplex.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals